Skip to main content

Dallan Murray

Analyst

Commercial Lead

Analyst

Commercial Activities

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dallan Murray

Dallan Murray is recorded as Analyst at Commercial Lead and Analyst at Commercial Activities. Sarepta Therapeutics, Inc. reported in an 8-K filed July 16, 2025 that Dallan Murray was terminated as Executive Vice President, Chief Customer Officer, effective July 18, 2025. The proxy statement of Sarepta Therapeutics, Inc. reports total compensation of $2,742,790 for Dallan Murray in fiscal 2025, including a base salary of $373,095. Disclosed compensation is on record for 4 fiscal years.

“On July 14, 2025, as part of the reduction in force, the Company terminated the employment of Dallan Murray, the Company's Executive Vice President, Chief Customer Officer, effective July 18, 2025.”
Sarepta Therapeutics, Inc. Form 8-K, filed July 16, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Sarepta Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Sarepta Therapeutics, Inc. (SRPT) $373,095 $2,742,790
2024 Sarepta Therapeutics, Inc. (SRPT) $621,842 $2,666,323
2023 Sarepta Therapeutics, Inc. (SRPT) — —
2022 Sarepta Therapeutics, Inc. (SRPT) — —

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.